Cell therapy demands that researchers optimize numerous variables during discovery and process development, including cell handling procedures, gene-editing components, expression constructs, cargo type and concentration, and electroporation conditions. Traditional approaches towards this can be labor-intensive and time-consuming, slowing progression from discovery to development. Furthermore, optimized conditions need to be transferable to larger-scale workflows without requiring re-optimization.
In this application note from MaxCyte, discover an electroporation platform that supports reproducible performance, delivers high cell viability, and enables seamless scaling for high-throughput screening.